C17H18N4O7
Neat
390.35
137391-68-5; (R)-4-Nitrobenzyl 2-diazo-4-((2R, 3S)-3-((R)-1-hydroxyethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate; 90822-24-5; Meropenem Impurity 13; (4-NITROPHENYL)METHYL (4R)-2-DIAZO-4-[(2R, 3S)-3-[(1R)-1-HYDROXYETHYL]-4-OXOAZETIDIN-2-YL]-3-OXOPENTANOATE; 2-Azetidinebutanoic-alpha-14C acid, alpha-diazo-3-(1-hydroxyethyl)-gamma-methyl-beta, 4-dioxo-, (4-nitrophenyl)methyl ester, [2R-[2alpha(R*), 3beta(R*)]]- (9CI); (3S, 4R)-3-[(1R)-1-Hydroxyethyl]-4-[(1R)-1-methyl-3-diazo-3-(p-nitrobenzyloxycarbonyl)-2-oxopropyl]az; 4-Nitrobenzyl (R)-2-diazo-4-((2R, 3S)-3-((R)-1-hydroxyethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate; MFCD11111990; C17H18N4O7; (R)-4-Nitrobenzyl 2-diazo-4-((2R, 3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate; 4-Nitrobenzyl (R)-2-Diazo-4-[(2R and 3S)-3-[(R)-1-hydroxyethyl]-4-oxo-2-azetidinyl]-3-oxopentanoate; Etapenem lmpurity 40; GEJ8U54SJZ; SCHEMBL306132; DTXSID10720045; FDXUXRZSNNSUGD-NRMKKVEVSA-N; AKOS016005347; FH38865; FM172290
(4-nitrophenyl)methyl (4R)-2-diazo-4-[(2R and 3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidin-2-yl]-3-oxopentanoate
InChI=1S/C17H18N4O7/c1-8(13-12(9(2)22)16(24)19-13)15(23)14(20-18)17(25)28-7-10-3-5-11(6-4-10)21(26)27/h3-6,8-9,12-13,22H,7H2,1-2H3,(H,19,24)/t8-,9-,12-,13-/m1/s1